EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
This article reports a clinical case of administration of canakinumab (Ilaris®), an interleukin-1β inhibitor, in a patient with chronic tophacaceous gout resistant to therapy with nonsteroidal anti-inflammatory drugs, glucocorticoids, and colchicine. The results show a good and long-term clinical ef...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2014-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839568467186941952 |
|---|---|
| author | Maksim Sergeyevna Eliseev O V Zhelyabin V G Barskova E L Nasonov |
| author_facet | Maksim Sergeyevna Eliseev O V Zhelyabin V G Barskova E L Nasonov |
| author_sort | Maksim Sergeyevna Eliseev |
| collection | DOAJ |
| description | This article reports a clinical case of administration of canakinumab (Ilaris®), an interleukin-1β inhibitor, in a patient with chronic tophacaceous gout resistant to therapy with nonsteroidal anti-inflammatory drugs, glucocorticoids, and colchicine. The results show a good and long-term clinical effect of the drug, which includes reduction of the number of painful and swollen joints and the absence of exacerbations during trial of the therapy of hyperuricemia. |
| format | Article |
| id | doaj-art-c2c83fc427ff47c8a37aba23b8c738db |
| institution | Matheson Library |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2014-03-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-c2c83fc427ff47c8a37aba23b8c738db2025-08-04T17:03:54ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-03-015219910110.14412/1995-4484-2014-99-1011305EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUTMaksim Sergeyevna Eliseev0O V Zhelyabin1V G Barskova2E L Nasonov3V.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaV.A. Nasonova Research Institute of Rheumatology, Russian Academy of Medical Sciences, Moscow, RussiaThis article reports a clinical case of administration of canakinumab (Ilaris®), an interleukin-1β inhibitor, in a patient with chronic tophacaceous gout resistant to therapy with nonsteroidal anti-inflammatory drugs, glucocorticoids, and colchicine. The results show a good and long-term clinical effect of the drug, which includes reduction of the number of painful and swollen joints and the absence of exacerbations during trial of the therapy of hyperuricemia.https://rsp.mediar-press.net/rsp/article/view/1365goutcanakinumabarthritis, uric acid |
| spellingShingle | Maksim Sergeyevna Eliseev O V Zhelyabin V G Barskova E L Nasonov EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT Научно-практическая ревматология gout canakinumab arthritis, uric acid |
| title | EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT |
| title_full | EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT |
| title_fullStr | EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT |
| title_full_unstemmed | EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT |
| title_short | EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT |
| title_sort | experience of administration of canakinumab an interleukin 1β inhibitor in a patient with chronic tophacaceous gout |
| topic | gout canakinumab arthritis, uric acid |
| url | https://rsp.mediar-press.net/rsp/article/view/1365 |
| work_keys_str_mv | AT maksimsergeyevnaeliseev experienceofadministrationofcanakinumabaninterleukin1binhibitorinapatientwithchronictophacaceousgout AT ovzhelyabin experienceofadministrationofcanakinumabaninterleukin1binhibitorinapatientwithchronictophacaceousgout AT vgbarskova experienceofadministrationofcanakinumabaninterleukin1binhibitorinapatientwithchronictophacaceousgout AT elnasonov experienceofadministrationofcanakinumabaninterleukin1binhibitorinapatientwithchronictophacaceousgout |